3.8 Article

Therapeutic effects of three trichothecenes in the silkworm infection assay with Candida albicans

Journal

DRUG DISCOVERIES AND THERAPEUTICS
Volume 10, Issue 1, Pages 44-48

Publisher

INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
DOI: 10.5582/ddt.2016.01013

Keywords

Antifungal; silkworm infection assay; trichothecenes; Candida albicans; cytotoxicity

Funding

  1. JSPS KAKENHI [22590013, 25460130, 21310146]
  2. Grants-in-Aid for Scientific Research [22590013, 25460130] Funding Source: KAKEN

Ask authors/readers for more resources

The silkworm infection assay is a useful method for directly evaluating the in vivo therapeutic effects of drug candidates. In the present study, 3 known trichothecenes, trichodermin, epiisororidin E, and verrucarin A, were evaluated as antifungal agents in the silkworm-Candida albicans assay. Trichodermin and epiisororidin E yielded effective therapeutic effects, while verrucarin A exhibited no efficacy in this assay system. These results strongly suggest that trichodermin and epiisororidin E are the lead compounds for developing a new antifungal agent.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available